title: Therapy with FK 506 in pediatric liver recipients.
authors.affiliation: Division of Pediatric, Mt Sinai Hospital, New York, NY 10029.
authors.forename: J R
authors.initials: JR
authors.lastname: Rosh
authors.forename: A H
authors.initials: AH
authors.lastname: Schwersenz
authors.forename: M
authors.initials: M
authors.lastname: Schwartz
authors.forename: V
authors.initials: V
authors.lastname: Moran
authors.forename: N
authors.initials: N
authors.lastname: Leleiko
authors.forename: V M
authors.initials: VM
authors.lastname: LeLeiko
authors.forename: C M
authors.initials: CM
authors.lastname: Miller
mesh_terms: D000293:Adolescent; D001663:Bilirubin / Q000097:blood; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000009:adverse effects; D005260:Female; D006085:Graft Survival; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D007223:Infant; D007239:Infections / Q000209:etiology; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008232:Lymphoproliferative Disorders / Q000209:etiology; D008297:Male; D012449:Safety; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D016572:Cyclosporine; D001663:Bilirubin; D016559:Tacrolimus